MyD88-dependent protective immunity elicited by adenovirus 5 expressing the surface antigen 1 from Toxoplasma gondii is mediated by CD8+ T lymphocytes-Reference-Cited by-同舟云学术

MyD88-dependent protective immunity elicited by adenovirus 5 expressing the surface antigen 1 from Toxoplasma gondii is mediated by CD8+ T lymphocytes

Published:2011-06 Issue:27 Volume:29 Page:4476-4484
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Mendes Érica A.,Caetano Bráulia C.,Penido Marcus L.O.,Bruna-Romero Oscar,Gazzinelli Ricardo T.

Funder

National Institute of Health

National Institute of Science and Technology for Vaccines/Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Programa de Desenvolvimento de Tecnologia e Insumos em Saúde from Fundação Oswaldo Cruz (PDTIS-FIOCRUZ)

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference68 articles.

1. Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications;Hartman;Virus Res,2008

2. Draper SJ, Heeney JL. Viruses as vaccine vectors for infectious diseases and cancer. Nat Rev Microbiol;8(1):62–73.

3. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes;Gao;Hum Gene Ther,2008

4. Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection;Bayer;J Virol,2010

5. Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination;Holst;J Immunol,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections;Pharmaceuticals;2023-02-22

2. Co-delivery of PLGA nanoparticles loaded with rSAG1 antigen and TLR ligands: An efficient vaccine against chronic toxoplasmosis;Microbial Pathogenesis;2022-01

3. Protection and Immune Responses Elicited by rSAG1-PLGA Nanoparticles in C57BL/6 Against Toxoplasma gondii;Journal of Medical Microbiology and Infectious Diseases;2021-03-01

4. Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: A systematic review;Comparative Immunology, Microbiology and Infectious Diseases;2020-04

5. T-cell profiles elicited by Toxoplasma gondii in acutely/chronically infected humans;Parasite Immunology;2018-04-30